Work

A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.tps5599

Authors: Dharmesh Gopalakrishnan, Jason Kirk, John Davis, Saby George, Ellis Glenn Levine, Jan Hendrik Beumer, Leonard Joseph Appleman, Dean Tang, Gurkamal S. Chatta

Institutions: Roswell Park Comprehensive Cancer Center, Georgetown University, UPMC Hillman Cancer Center, NSABP Foundation, UPMC Health System

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AbbVie, National Institutes of Health

OpenAlex ID: W3030615514

Cites:

Cited by: 2

Related to: 10